Michael Castagna
Vorstandsvorsitzender bei MANNKIND CORPORATION
Vermögen: 10 Mio $ am 30.04.2024
Profil
Michael E.
Castagna is currently the Chief Executive Officer & Director at MannKind Corp.
He is also a Director at Pet Partners.
Previously, he held positions as the Executive Director-Immunology Franchise at Bristol Myers Squibb Co. from 2010 to 2012, Director at Pharmasset, Inc. in 2005-2006, Vice President-Global Commercial at Amgen, Inc. from 2012 to 2016, and Vice President & Head-Biopharmaceuticals at Sandoz, Inc. from 2009 to 2010.
He also served as the VP & Head-North America Biopharmaceuticals at Novartis AG.
Dr. Castagna obtained a doctorate degree from Massachusetts College of Pharmacy & Health Science in 2014, an MBA from The Wharton School of the University of Pennsylvania in 2005, and an undergraduate degree from Philadelphia College of Pharmacy in 2000.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MANNKIND CORPORATION
0,93% | 18.05.2024 | 2 511 230 ( 0,93% ) | 10 Mio $ | 30.04.2024 |
Aktive Positionen von Michael Castagna
Unternehmen | Position | Beginn |
---|---|---|
MANNKIND CORPORATION | Vorstandsvorsitzender | 25.05.2017 |
Pet Partners | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Castagna
Unternehmen | Position | Ende |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 14.03.2016 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.11.2012 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.11.2010 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Direktor/Vorstandsmitglied | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Ausbildung von Michael Castagna
Massachusetts College of Pharmacy & Health Science | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Philadelphia College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
AMGEN INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
MANNKIND CORPORATION | Health Technology |
NOVARTIS AG | Health Technology |
Private Unternehmen | 3 |
---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Pet Partners |